Русский
English
+7 (495) 676-43-60
Leninsky Prospekt, 9
Consulting channel for pharmaceutical market participants
pharmprom@gilsinp.ru
About
Message from Director
About Institute
History
Leadership
Payment details
Useful links
Frequently asked questions
Activities
Inspectorate
Industry Analytics Center
Monitoring of industry markets and government programs
National Centre for Reference Standards
Eurasian Academy of Good Practices
Medical center
Events
GMP-conference
GxP-fest
Semashko Pharmaceutical Forum
Documents
Departmental orders, regulatory legal acts
Inspection
R&D
Medical activity
Good engineering practices
Quality management system
Data Integrity and validation of computerized systems
Press center
News
Publications
Logotypes
Principles of interaction with media
Contacts
Fighting Corruption
Front page
»
Events
»
Application of risk analysis in selection of validation objects
Application of risk analysis in selection of validation objects
Date:
31 Jan. – 01 Feb. 2019
Latest news
International Forum of Pharmaceutical Inspectorates: A Step Towards Global Harmonization of Standards
November 26, 2024, Dubai, United Arab Emirates The International Forum of Pharmaceutical Inspectorates has...
12/6/2024
FSI “SID & GP” and CDSCO, India signed a cooperation agreement.
The FSI “SID & GP” and Central Drugs Standard Control Organization (CDSCO), India signed a...
10/21/2024
The importance of reference samples in the development of pharmaceutical industry was discussed during the meeting of the Healthcare Commission of the General Council of the UNITED RUSSIA Party
The meeting of the Healthcare Commission on “Government regulation of medicinal products marketing. National system...
10/3/2024
All news
2024 © News and other data on this site are provided for information purposes only, and are not intended for republication or redistribution. Republication or redistribution content is expressly prohibited without the prior written consent of Division for International Cooperation and External Communications FSI «SID and GP».